MyMD Pharmaceuticals Statistics
Total Valuation
MYMD has a market cap or net worth of $6.06 million. The enterprise value is $1.19 million.
| Market Cap | 6.06M |
| Enterprise Value | 1.19M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MYMD has 2.16 million shares outstanding. The number of shares has increased by 19.18% in one year.
| Shares Outstanding | 2.16M |
| Shares Change (YoY) | +19.18% |
| Shares Change (QoQ) | +2.95% |
| Owned by Insiders (%) | 7.32% |
| Owned by Institutions (%) | 9.60% |
| Float | 1.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.17 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.60% and return on invested capital (ROIC) is -131.74%.
| Return on Equity (ROE) | -63.60% |
| Return on Assets (ROA) | -35.20% |
| Return on Capital (ROIC) | -131.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.37M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.96% in the last 52 weeks. The beta is 3.17, so MYMD's price volatility has been higher than the market average.
| Beta (1Y) | 3.17 |
| 52-Week Price Change | -94.96% |
| 50-Day Moving Average | 2.86 |
| 200-Day Moving Average | 13.27 |
| Relative Strength Index (RSI) | 54.69 |
| Average Volume (30 Days) | 227,837 |
Short Selling Information
The latest short interest is 392,998, so 18.21% of the outstanding shares have been sold short.
| Short Interest | 392,998 |
| Short Previous Month | 109,130 |
| Short % of Shares Out | 18.21% |
| Short % of Float | 20.31% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.36M |
| Pretax Income | -4.00M |
| Net Income | -8.22M |
| EBITDA | -4.00M |
| EBIT | -4.00M |
| Earnings Per Share (EPS) | -$5.33 |
Balance Sheet
The company has $4.92 million in cash and $48,870 in debt, giving a net cash position of $4.87 million or $2.26 per share.
| Cash & Cash Equivalents | 4.92M |
| Total Debt | 48,870 |
| Net Cash | 4.87M |
| Net Cash Per Share | $2.26 |
| Equity / Book Value | 12.37M |
| Book Value Per Share | 5.73 |
| Working Capital | 828,253 |
Cash Flow
| Operating Cash Flow | -12.98M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.98M |
| FCF Per Share | -$8.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MYMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.18% |
| Shareholder Yield | -19.18% |
| Earnings Yield | -135.55% |
| FCF Yield | -214.10% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 15, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Feb 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |